SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: arnie h who wrote (1505)10/23/1998 10:44:00 PM
From: wolfdog2  Read Replies (1) | Respond to of 2173
 
Arnie, their cash is $10 million net of current liabilities. In Q3 they ran a $16 million deficit. Since they have now laid off 3/4 of their work force, I would assume that the company can continue in business for another 5 to 6 months.



To: arnie h who wrote (1505)10/24/1998 9:24:00 AM
From: Rudy Saucillo  Read Replies (1) | Respond to of 2173
 
Arnie, I don't have the data with me but I recall that they had $25M in cash and equivalents at the end of Sept. (I'll verify and post if this is incorrect.) With their layoff and ramping up of several trials in 2 programs, it's very difficult to estimate a new burn rate. I believe the real question is if they have a chance of landing a new partner in the near term for either program. I'm sure you can guess my opinion. Rudy


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News